臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856704
	造訪人次 : 53660333 線上人數 : 2403 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yu c j"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 6-15 / 2308 (共231頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-09-15T01:09:03Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Chia-Chi Lin; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-09-15T01:08:54Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Chia-Chi Lin; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-09-15T01:08:50Z	Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC	Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Chia-Chi Lin; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H.
臺大學術典藏	2022-09-07T06:39:11Z	Latent tuberculosis infection increases in kidney transplantation recipients compared with transplantation candidates: A neglected perspective in tuberculosis control	Shu C.-C.; Tsai M.-K.; SHU-WEN LIN; Wang J.-Y.; Yu C.-J.; Lee C.-Y.
臺大學術典藏	2022-09-07T06:39:09Z	CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis	Wang P.-H.; Lin S.-Y.; Lee S.S.-J.; SHU-WEN LIN; Lee C.-Y.; Wei Y.-F.; Shu C.-C.; Wang J.-Y.; Yu C.-J.
臺大學術典藏	2022-09-07T06:39:08Z	Completion and adverse drug events of latent tuberculosis infection treatment in patients receiving dialysis: Predictors and impacts of different regimens in a prospective cohort study	Lin S.-Y.; Feng J.-Y.; Lee C.-Y.; Lin Y.-C.; Chou Y.-H.; Lin K.-Y.; Wei Y.-F.; SHU-WEN LIN; Chang C.-H.; Wang P.-H.; Shu C.-C.; Wang J.-Y.; Yu C.-J.
臺大學術典藏	2022-09-06T02:43:06Z	Changes of heart rate variability during ventilator weaning	Shen H.-N.; LIAN-YU LIN; Chen K.-Y.; Kuo P.-H.; Yu C.-J.; Wu H.-D.; Yang P.-C.
臺大學術典藏	2022-08-19T00:21:14Z	Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials	CHIUN HSU; Cheng A.-L.; Yang P.-C.; Yu C.-J.; Yang C.-H.; Kuo S.-H.
臺大學術典藏	2022-08-19T00:21:13Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Shih J.-Y.; CHIUN HSU; Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2022-08-19T00:21:10Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Yang P.-C.; Chang G.-C.; CHIUN HSU; Gow C.-H.; Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.

顯示項目 6-15 / 2308 (共231頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目